ST. LOUIS--(BUSINESS WIRE)--Covidien (NYSE: COV, BSX: COV), a leading global provider of healthcare products, today announced that it has signed an agreement with Pinyons Medical Technology Inc., a privately-held company based in Park City, Utah, and its President and CEO, Shawn Fojtik, to acquire all assets related to the Pinyons POWRSyringe Injector and POWRSyringe Monitor handheld, manual injection and inflation devices. These devices facilitate manual x-ray contrast media injections during angiography procedures performed in the cardiac catheterization laboratory and interventional radiology suite.
